PROVECTUS BIOPHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $10.7M | $8.1M |
| FY2011 | — | $10.0M | $7.7M |
| FY2012 | — | $4.4M | $1.2M |
| FY2013 | — | $6.6M | $15.7M |
| FY2014 | — | $25.2M | $17.4M |
| FY2015 | — | $16.3M | $14.2M |
| FY2016 | — | $3.5M | $1.2M |
| FY2017 | — | $-10.0M | $105.5K |
| FY2018 | — | $-17.4M | $51.0K |
| FY2019 | — | $-24.1M | $590.7K |